KDM2B-IN-4
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-139601-1MG | 1 mg | 368,00 | Add | |
| HY-139601-1ML | 10mM/1mL | 863,00 | Add | |
| HY-139601-5MG | 5 mg | 1'040,00 | Add | |
| HY-139601-10MG | 10 mg | 1'660,00 | Add | |
| HY-139601-25MG | 25 mg | 3'433,00 | Add | |
| HY-139601-50MG | 50 mg | 5'485,00 | Add | |
| HY-139601-100MG | 100 mg | 8'817,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
KDM2B-IN-4 is a histone demethylase KDM2B inhibitor extracted from patent WO2016112284A1, compound 182b. KDM2B-IN-4 can be used for the research of cancer[1].
| Category | Inhibitor |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Epigenetics |
| Format | Solubility: DMSO : 100 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.59% |
| Molecular Formula | C24H28N2O2 |
| Molecular Weight | 376.49 |
| CAS-Number | 1966933-85-6 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
